Pharmacovigilance and Drug Safety Software Market is Projected to Reach Valuation of US$143.6 mn by 2022 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Pharmacovigilance and Drug Safety Software Market is Projected to Reach Valuation of US$143.6 mn by 2022

Description:

The world pharmacovigilance and drug safety software market is expected to embrace favorable opportunities on the back of government policies related to drug safety regulations and rising rates of cases that pertain to adverse drug reaction. Pharmacovigilance and drug safety software market to rise at a 5.4% CAGR between 2017 and 2022. In 2017, the market had earned revenue of US$143.6 mn. By the completion of 2022, it could expand its valuation to a US$187.0 mn. – PowerPoint PPT presentation

Number of Views:15
Date added: 4 May 2020
Slides: 8
Provided by: poojamahajan

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Pharmacovigilance and Drug Safety Software Market is Projected to Reach Valuation of US$143.6 mn by 2022


1
Pharmacovigilance and Drug Safety Software Market
  • Pharmacovigilance and Drug Safety Software Market
    Segmentation by Software - Adverse Event
    Reporting Software, Drug Safety Audits Software,
    Issue Tracking Software, and Fully Integrated
    Software End User - Pharma and Biotech
    Companies, CROs, BPO Firms, and Pharmacovigilance
    Service Providers Delivery Mode - On-premise and
    Cloud-based and Forecast 2017 - 2022

2019 Transparency Market Research, All Rights
Reserved
2
Table of Content
Sr. No. Content
Chapter 1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Market Overview
Chapter 4 Market Dynamics
Chapter 5 Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts, By Software Type
Chapter 6 Global Pharmacovigilance and Drug Safety Software Market Analysis, by Modality
Chapter 7 Global Pharmacovigilance and Drug Safety Software Market Analysis, by Application
Chapter 8 Global Pharmacovigilance and Drug Safety Software Market Analysis, by End-user
Chapter 9 Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecast by Region
Chapter 10 North America Pharmacovigilance and Drug Safety Software Market Analysis and Forecast
Chapter 11 Europe Pharmacovigilance and Drug Safety Software Market Analysis and Forecast
Chapter 12 Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis and Forecast
Chapter 13 Latin America Pharmacovigilance and Drug Safety Software Market Analysis and Forecast
Chapter 14 Middle East Africa Pharmacovigilance and Drug Safety Software Market Analysis and Forecast
Chapter 15 Competition Landscape
2019 Transparency Market Research, All Rights
Reserved
3
Pharmacovigilance and Drug Safety Software Market
- Snapshot
  • Pharmacovigilance is the profession of monitoring
    medical drug effects after being licensed.
  • The global pharmacovigilance and drug safety
    software market is envisioned to attract benefits
    while riding on the ability of products to avert,
    evaluate, and uncover enduring and temporary side
    effects of certain medications.
  • Pharmacovigilance software could help to inhibit
    unnecessary future events and determine the cause
    of withdrawal.
  • Companies are prominently enabled to put into
    practice proactive safety surveillance programs
    with the support provided by pharmacovigilance
    software as they push new limits in the market.

2019 Transparency Market Research, All Rights
Reserved
4
(No Transcript)
5
Reports Highlights
  • The global pharmacovigilance and drug safety
    software market to rise at a 5.4 CAGR between
    2017 and 2022.
  • Rising withdrawals of high-profile drugs has been
    foretold to augment the employment of
    pharmacovigilance tools in the near future.
  • The usage of these tools could also gain growth
    because of the swelling pressure on drug
    manufacturers to determine early signs of adverse
    interactions due to drug consumption.
  • The demand in the world pharmacovigilance and
    drug safety software market could be bolstered
    with advancement in technology.

6
Continue..
  • The top players of global pharmacovigilance and
    drug safety software market could be more into
    benefit due to the associated use of cutting-edge
    softwares like Argus and ARISg.
  • With easy accessible data and reduced use of
    outdated data, it has become easier for players
    to adopt pharmacovigilance softwares into the
    market.
  • Some of the leading players of the market are
    United BioSource Corporation, AB Cube, and UMBRA
    Global LLC.
  • Players could testify of quick business
    opportunities owing to the implementation of such
    strategies during their operation.

2019 Transparency Market Research, All Rights
Reserved
7
Contact
  • To know more about us, please visit our website
  • www.transparencymarketresearch.com
  • For sales queries or new topics email us on
  • sales_at_transparencymarketresearch.com
  • Thank You

2019 Transparency Market Research, All Rights
Reserved
About PowerShow.com